All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

Michael Manns; Stanislas Pol; Ira M Jacobson; Patrick Marcellin; Stuart C Gordon; Cheng-Yuan Peng; Ting-Tsung Chang; Gregory T Everson; Jeong Heo; Guido Gerken; Boris Yoffe; William J Towner; Marc Bourliere; Sophie Metivier; Chi-Jen Chu; William Sievert; Jean-Pierre Bronowicki; Dominique Thabut; Youn-Jae Lee; Jia-Horng Kao; Fiona McPhee; Justin Kopit; Patricia Mendez; Misti Linaberry; Eric Hughes; Stephanie Noviello

首页> 外文期刊>The Lancet >All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

【24h】

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

机译：All-Oral Daclatasvir Plus Asunaprevir用于丙型肝炎病毒基因型1B：跨国，第3阶段，多辅曲线研究。

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Bristol-Myers Squibb.

机译：Bristol-Myers Squibb。

著录项

来源
《The Lancet》 |2014年第9954期|共9页
作者
Michael Manns; Stanislas Pol; Ira M Jacobson; Patrick Marcellin; Stuart C Gordon; Cheng-Yuan Peng; Ting-Tsung Chang; Gregory T Everson; Jeong Heo; Guido Gerken; Boris Yoffe; William J Towner; Marc Bourliere; Sophie Metivier; Chi-Jen Chu; William Sievert; Jean-Pierre Bronowicki; Dominique Thabut; Youn-Jae Lee; Jia-Horng Kao; Fiona McPhee; Justin Kopit; Patricia Mendez; Misti Linaberry; Eric Hughes; Stephanie Noviello;
展开▼
作者单位

Bristol-Myers Squibb Research and Development Princeton NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医药、卫生;
关键词

相似文献

外文文献
中文文献
专利

1. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. [J] . Michael Manns, Stanislas Pol, Ira M Jacobson, The Lancet . 2014,第9954期

机译：All-Oral Daclatasvir Plus Asunaprevir用于丙型肝炎病毒基因型1B：跨国，第3阶段，多辅曲线研究。
2. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. [J] . Michael Manns, Stanislas Pol, Ira M Jacobson, The Lancet . 2014,第9954期

机译：丙型肝炎病毒基因型1b的全口服达卡他韦加阿司那普韦：一项跨国，三期，多队列研究。
3. All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study. [J] . Michael Manns, Stanislas Pol, Ira M Jacobson, The Lancet . 2014,第9954期

机译：丙型肝炎病毒基因型1b的全口服达卡他韦加阿司那普韦：一项跨国，三期，多队列研究。
4. Genotype and Serotype Identification of Hepatitis B Virus in Chronic Hepatitis B Patients Treated with Telbivudine [C] . Y Purnamasari, Tien, Arimaswati, International Seminar on Smart Molecule of Natural Resources . 2020

机译：临床治疗慢性乙型肝炎患者乙型肝炎病毒的基因型和血清型鉴定
5. Preclinical development of a prophylactic genotype 1a/1b consensus hepatitis C virus DNA vaccine. [D] . Latimer, Brian Paul. 2014

机译：预防性基因型1a / 1b共识性丙型肝炎病毒DNA疫苗的临床前开发。
6. Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection [O] . Naoki Morishita, Ryotaro Sakamori, Tomomi Yamada, 2020

机译：具有NS5A L31M / V-Y93H双取代的预先存在的次要变体与AsunaPrevir Plus Daclatasvir治疗的病毒衰竭与基因型1B丙型肝炎病毒感染密切相关
7. Pre-existing minor variants with NS5A L31M/V-Y93H double substitution are closely linked to virologic failure with asunaprevir plus daclatasvir treatment for genotype 1b hepatitis C virus infection [O] . Naoki Morishita, Ryotaro Sakamori, Tomomi Yamada, 2020

机译：具有NS5A L31M / V-Y93H双取代的预先存在的次要变体与AsunaPrevir Plus Daclatasvir治疗的病毒衰竭与基因型1B丙型肝炎病毒感染密切相关

All-oral daclatasvir plus asunaprevir for hepatitis C virus genotype 1b: a multinational, phase 3, multicohort study.

摘要

著录项

相似文献

相关主题

期刊订阅